NGL FINE CHEM LIMITED (NGLFINE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]

NGLFINEUpdated 7 Sept 2026, 8:25

Ngl Fine Chem Limited

Market Cap

₹1,797Cr.

Current Price

₹2,908

High / Low

₹3,602/1,261

Stock P/E

35.6

Book Value₹518
Dividend Yield0.06%
ROCE16.7%
ROE15.6%
Face Value₹5.00

About

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days107123110897963537486928194
Inventory Days10690114134106154132133699995101
Days Payable150122139187921149484591109489
Cash Conversion Cycle639185359310391124978283106
Working Capital Days384945187063718967715159
ROCE %29%37%34%22%28%15%52%35%12%19%8%17%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 7 September 2026 at 8:25


Designed & Shipped by Harshit Bansal